Official Description of Sulphatidin
Name
Sulphatidin
(An integrative CHON-balancing therapeutic formulation for Metachromatic Leukodystrophy, Neuropathy, and Diabetes)
Composition
Chromium Salt (trace mineral regulator)
Nitric Acid (HNO₃) – source of nitrogen and nitric oxide precursor
Sulphuric Acid (H₂SO₄) – sulphur donor, balanced in neutralized micro-form
Scientific Rationale
- Medical Science Aspect
Chromium improves insulin sensitivity, regulates lipid and glucose metabolism, and reduces oxidative stress.
Nitric Acid provides Nitrogen, supporting enzyme functions and neurotransmitter regulation. It may act as a nitric oxide donor, improving vascular perfusion and neuronal function.
Sulphuric Acid provides Sulphur, which has a direct biochemical link with sulfatide metabolism (the primary pathological substrate in MLD).
- CHON Balancing Theory Aspect
Metachromatic Leukodystrophy (MLD) shows a typical CHON imbalance:
Carbon Excess → Lipid (sulfatide) accumulation
Oxygen Excess → Oxidative stress
Hydrogen Deficiency → Mitochondrial energy crisis
Nitrogen Deficiency → Enzyme and neurotransmitter dysfunction
Sulphatidin restores balance by:
Chromium → Reducing Carbon & Oxygen excess (lipid & oxidative control)
Nitric Acid → Correcting Nitrogen deficiency (enzyme + neurotransmitter support)
Sulphuric Acid → Regulating sulfatide metabolism via Sulphur balance
Indirect Hydrogen support → Better energy utilization via improved insulin action
Indications
Metachromatic Leukodystrophy (MLD): Supports sulfatide metabolism, reduces oxidative stress, improves neuronal energy utilization.
Peripheral Neuropathy: Enhances vascular perfusion (via nitric oxide), reduces oxidative damage.
Diabetes Mellitus: Improves insulin sensitivity, glucose utilization, and lipid profile.
Proposed Mechanism of Action
Sulphatidin = Chromium + Nitrogen + Sulphur balance
→ Normalizes CHON imbalance
→ Reduces toxic accumulation
→ Supports mitochondrial function
→ Protects nerve myelin and improves energy metabolism
Summary
Sulphatidin is a novel CHON-balancing therapeutic formulation designed for neuro-metabolic and metabolic disorders. By targeting lipid accumulation, oxidative stress, and enzyme dysfunction, it offers a multi-dimensional approach in conditions like Metachromatic Leukodystrophy, Neuropathy, and Diabetes.
